IL17A and myocardial infarction: Evidence indicates that IL-17A may have a safeguarding role in certain scenarios, like in individuals experiencing a heart attack, where reduced levels of IL-17A in the bloodstream have been associated with mortality and repeated severe cardiovascular incidents.